QQQ   268.40 (-1.13%)
AAPL   446.21 (+0.40%)
MSFT   207.29 (-2.44%)
FB   261.21 (-2.69%)
GOOGL   1,481.83 (-1.10%)
AMZN   3,124.84 (-1.35%)
NVDA   441.00 (-1.56%)
CGC   18.09 (+8.78%)
BABA   246.66 (-2.16%)
TSLA   1,416.23 (-2.51%)
MU   48.65 (-0.21%)
GE   6.62 (+3.44%)
AMD   81.16 (-4.35%)
T   30.14 (+0.40%)
F   7.09 (+3.35%)
ACB   10.21 (-0.58%)
GILD   68.46 (-1.28%)
NFLX   482.55 (-2.46%)
DIS   129.60 (-0.25%)
BAC   26.63 (+1.99%)
BA   176.29 (+3.69%)
QQQ   268.40 (-1.13%)
AAPL   446.21 (+0.40%)
MSFT   207.29 (-2.44%)
FB   261.21 (-2.69%)
GOOGL   1,481.83 (-1.10%)
AMZN   3,124.84 (-1.35%)
NVDA   441.00 (-1.56%)
CGC   18.09 (+8.78%)
BABA   246.66 (-2.16%)
TSLA   1,416.23 (-2.51%)
MU   48.65 (-0.21%)
GE   6.62 (+3.44%)
AMD   81.16 (-4.35%)
T   30.14 (+0.40%)
F   7.09 (+3.35%)
ACB   10.21 (-0.58%)
GILD   68.46 (-1.28%)
NFLX   482.55 (-2.46%)
DIS   129.60 (-0.25%)
BAC   26.63 (+1.99%)
BA   176.29 (+3.69%)
QQQ   268.40 (-1.13%)
AAPL   446.21 (+0.40%)
MSFT   207.29 (-2.44%)
FB   261.21 (-2.69%)
GOOGL   1,481.83 (-1.10%)
AMZN   3,124.84 (-1.35%)
NVDA   441.00 (-1.56%)
CGC   18.09 (+8.78%)
BABA   246.66 (-2.16%)
TSLA   1,416.23 (-2.51%)
MU   48.65 (-0.21%)
GE   6.62 (+3.44%)
AMD   81.16 (-4.35%)
T   30.14 (+0.40%)
F   7.09 (+3.35%)
ACB   10.21 (-0.58%)
GILD   68.46 (-1.28%)
NFLX   482.55 (-2.46%)
DIS   129.60 (-0.25%)
BAC   26.63 (+1.99%)
BA   176.29 (+3.69%)
QQQ   268.40 (-1.13%)
AAPL   446.21 (+0.40%)
MSFT   207.29 (-2.44%)
FB   261.21 (-2.69%)
GOOGL   1,481.83 (-1.10%)
AMZN   3,124.84 (-1.35%)
NVDA   441.00 (-1.56%)
CGC   18.09 (+8.78%)
BABA   246.66 (-2.16%)
TSLA   1,416.23 (-2.51%)
MU   48.65 (-0.21%)
GE   6.62 (+3.44%)
AMD   81.16 (-4.35%)
T   30.14 (+0.40%)
F   7.09 (+3.35%)
ACB   10.21 (-0.58%)
GILD   68.46 (-1.28%)
NFLX   482.55 (-2.46%)
DIS   129.60 (-0.25%)
BAC   26.63 (+1.99%)
BA   176.29 (+3.69%)
Log in

NASDAQ:MGNXMacroGenics News Headlines

$28.95
+1.53 (+5.58 %)
(As of 08/10/2020 11:44 AM ET)
Add
Compare
Today's Range
$28.19
Now: $28.95
$29.20
50-Day Range
$25.26
MA: $27.91
$31.51
52-Week Range
$4.04
Now: $28.95
$32.18
Volume3,724 shs
Average Volume443,051 shs
Market Capitalization$1.57 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.75

Headlines

MacroGenics (NASDAQ MGNX) News Headlines

Source:
DateHeadline
MacroGenics (NASDAQ:MGNX) Lowered to Hold at Zacks Investment ResearchMacroGenics (NASDAQ:MGNX) Lowered to Hold at Zacks Investment Research
marketbeat.com - August 5 at 4:27 AM
MacroGenics Inc (NASDAQ:MGNX) Short Interest UpdateMacroGenics Inc (NASDAQ:MGNX) Short Interest Update
americanbankingnews.com - August 7 at 7:55 PM
MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewswireMacroGenics to Participate in Upcoming Investor Conferences - GlobeNewswire
globenewswire.com - August 5 at 5:00 PM
Short Interest in MacroGenics Inc (NASDAQ:MGNX) Drops By 9.4%Short Interest in MacroGenics Inc (NASDAQ:MGNX) Drops By 9.4%
americanbankingnews.com - August 3 at 7:10 PM
MacroGenics (NASDAQ:MGNX) Downgraded to Neutral at CitigroupMacroGenics (NASDAQ:MGNX) Downgraded to Neutral at Citigroup
www.americanbankingnews.com - August 3 at 8:29 AM
MacroGenics Inc (NASDAQ:MGNX) Expected to Post Quarterly Sales of $14.88 MillionMacroGenics Inc (NASDAQ:MGNX) Expected to Post Quarterly Sales of $14.88 Million
www.americanbankingnews.com - August 3 at 3:01 AM
MacroGenics (NASDAQ:MGNX) Issues  Earnings Results, Misses Estimates By $0.02 EPSMacroGenics (NASDAQ:MGNX) Issues Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - August 1 at 8:12 PM
-$0.85 EPS Expected for MacroGenics Inc (NASDAQ:MGNX) This Quarter-$0.85 EPS Expected for MacroGenics Inc (NASDAQ:MGNX) This Quarter
www.americanbankingnews.com - August 1 at 9:09 AM
MacroGenics (MGNX) Q2 2020 Earnings Call Transcript - Motley FoolMacroGenics (MGNX) Q2 2020 Earnings Call Transcript - Motley Fool
www.fool.com - August 1 at 8:53 AM
MacroGenics (MGNX) Q2 2020 Earnings Call TranscriptMacroGenics (MGNX) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 1 at 3:52 AM
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q2 2020 Results - Earnings Call Transcript - Seeking AlphaMacroGenics, Inc. (MGNX) CEO Scott Koenig on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 31 at 10:52 PM
Edited Transcript of MGNX.OQ earnings conference call or presentation 30-Jul-20 8:30pm GMT - Yahoo FinanceEdited Transcript of MGNX.OQ earnings conference call or presentation 30-Jul-20 8:30pm GMT - Yahoo Finance
finance.yahoo.com - July 31 at 5:51 PM
MacroGenics (NASDAQ:MGNX) Stock Rating Reaffirmed by HC WainwrightMacroGenics (NASDAQ:MGNX) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - July 31 at 9:27 AM
MacroGenics (NASDAQ:MGNX) Price Target Increased to $12.00 by Analysts at Morgan StanleyMacroGenics (NASDAQ:MGNX) Price Target Increased to $12.00 by Analysts at Morgan Stanley
www.americanbankingnews.com - July 31 at 9:26 AM
ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results - Business WireImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results - Business Wire
www.businesswire.com - July 31 at 7:51 AM
Is MacroGenics, Inc. (NASDAQ:MGNX) Trading At A 37% Discount?Is MacroGenics, Inc. (NASDAQ:MGNX) Trading At A 37% Discount?
finance.yahoo.com - July 31 at 7:51 AM
Macrogenics (MGNX) Tops Q2 EPS by 8c, Revenues Beat - StreetInsider.comMacrogenics (MGNX) Tops Q2 EPS by 8c, Revenues Beat - StreetInsider.com
www.streetinsider.com - July 30 at 8:21 PM
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceMacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - July 30 at 8:21 PM
MacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial Results - GlobeNewswireMacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial Results - GlobeNewswire
www.globenewswire.com - July 30 at 8:21 PM
MacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial ResultsMacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial Results
finance.yahoo.com - July 30 at 8:21 PM
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue EstimatesMacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - July 30 at 8:21 PM
MacroGenics Inc (NASDAQ:MGNX) Receives Average Rating of "Buy" from AnalystsMacroGenics Inc (NASDAQ:MGNX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 28 at 4:13 PM
MacroGenics (MGNX) Scheduled to Post Earnings on ThursdayMacroGenics (MGNX) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - July 24 at 9:18 AM
Earnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline - Yahoo FinanceEarnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - July 23 at 9:53 AM
MacroGenics Announces Date of Second Quarter 2020 Financial Results Conference Call - Yahoo FinanceMacroGenics Announces Date of Second Quarter 2020 Financial Results Conference Call - Yahoo Finance
finance.yahoo.com - July 23 at 9:53 AM
MacroGenics Announces Date of Second Quarter 2020 Financial Results Conference CallMacroGenics Announces Date of Second Quarter 2020 Financial Results Conference Call
finance.yahoo.com - July 23 at 9:53 AM
Earnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline - NasdaqEarnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline - Nasdaq
www.nasdaq.com - July 22 at 2:38 PM
Earnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to DeclineEarnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline
finance.yahoo.com - July 22 at 2:38 PM
MacroGenics (NASDAQ:MGNX) PT Raised to $11.00MacroGenics (NASDAQ:MGNX) PT Raised to $11.00
www.americanbankingnews.com - July 16 at 6:07 AM
Heres Why MacroGenics Jumped 156.6% in the First Half of 2020 - Motley FoolHere's Why MacroGenics Jumped 156.6% in the First Half of 2020 - Motley Fool
www.fool.com - July 10 at 8:42 AM
MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer - GlobeNewswireMacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer - GlobeNewswire
www.globenewswire.com - July 9 at 7:15 PM
Here's Why MacroGenics Jumped 156.6% in the First Half of 2020Here's Why MacroGenics Jumped 156.6% in the First Half of 2020
finance.yahoo.com - July 9 at 7:15 PM
MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric CancerMacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer
finance.yahoo.com - July 9 at 7:15 PM
The Play On MacroGenics - Seeking AlphaThe Play On MacroGenics - Seeking Alpha
seekingalpha.com - July 6 at 7:46 PM
Is MacroGenics Inc (MGNX) A Good Stock To Buy? - Yahoo FinanceIs MacroGenics Inc (MGNX) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - June 28 at 12:24 AM
Is MacroGenics Inc (MGNX) A Good Stock To Buy?Is MacroGenics Inc (MGNX) A Good Stock To Buy?
finance.yahoo.com - June 28 at 12:24 AM
BRIEF-Macrogenics Announces Presentation Of Preclinical Data - ReutersBRIEF-Macrogenics Announces Presentation Of Preclinical Data - Reuters
www.reuters.com - June 22 at 12:57 PM
MacroGenics Announces Presentation of Preclinical Data at the 2020 AACR Annual Meeting - GlobeNewswireMacroGenics Announces Presentation of Preclinical Data at the 2020 AACR Annual Meeting - GlobeNewswire
www.globenewswire.com - June 22 at 12:57 PM
MacroGenics Announces Presentation of Preclinical Data at the 2020 AACR Annual MeetingMacroGenics Announces Presentation of Preclinical Data at the 2020 AACR Annual Meeting
finance.yahoo.com - June 22 at 12:57 PM
MacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer - GlobeNewswireMacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer - GlobeNewswire
www.globenewswire.com - June 16 at 8:38 AM
MacroGenics Appoints Dr. Stephen Eck As Chief Medical OfficerMacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer
finance.yahoo.com - June 16 at 8:38 AM
Macrogenics (MGNX) Announces Margetuximab Granted Orphan Drug Designation in the US for Gastric Cancer - StreetInsider.comMacrogenics (MGNX) Announces Margetuximab Granted Orphan Drug Designation in the US for Gastric Cancer - StreetInsider.com
www.streetinsider.com - June 6 at 12:14 AM
MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S. for Gastric Cancer - GlobeNewswireMacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S. for Gastric Cancer - GlobeNewswire
www.globenewswire.com - June 5 at 2:13 PM
Why MacroGenics Is Moving TodayWhy MacroGenics Is Moving Today
www.benzinga.com - June 5 at 11:36 AM
MacroGenics margetuximab an Orphan Drug in U.S. for gastric cancerMacroGenics' margetuximab an Orphan Drug in U.S. for gastric cancer
seekingalpha.com - June 5 at 9:11 AM
MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S. for Gastric CancerMacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S. for Gastric Cancer
finance.yahoo.com - June 5 at 9:11 AM
MacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid Leukemia - GlobeNewswireMacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid Leukemia - GlobeNewswire
www.globenewswire.com - June 3 at 7:08 PM
MacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid LeukemiaMacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid Leukemia
finance.yahoo.com - June 3 at 7:08 PM
UPDATE: Guggenheim Upgrades MacroGenics (MGNX) to Buy - StreetInsider.comUPDATE: Guggenheim Upgrades MacroGenics (MGNX) to Buy - StreetInsider.com
www.streetinsider.com - June 1 at 9:07 AM
Heres Why MacroGenics Is Tumbling 17.3% Today - Motley FoolHere's Why MacroGenics Is Tumbling 17.3% Today - Motley Fool
www.fool.com - May 29 at 1:12 PM
Heres Why MacroGenics Is Tumbling 17.3% TodayHere's Why MacroGenics Is Tumbling 17.3% Today
finance.yahoo.com - May 29 at 1:11 PM
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.